Search

everythinglearnresearchcommunity

for

Search:↓

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

The document concludes that more research is needed to fully understand the causes of PCOS.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Balding men have higher heart disease risk.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

New treatments for PCOS focus on managing symptoms and improving fertility.

Lower ghrelin levels and certain gene variations may increase acne risk.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

Resistance training might help with PCOS symptoms, but more research is needed.

Women with PCOS who have high male hormone levels often also have insulin resistance.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Irisin and GIP levels are not linked to BMI in women, regardless of PCOS status.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Traditional Chinese Medicine and acupuncture may improve Polycystic Ovarian Syndrome symptoms and reduce costs, but more research is needed.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

Adequate vitamin D might lower, and high hair chromium might increase DNA damage in obese women.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

Combining modern and Unani medicine may better manage PCOS symptoms.